期刊文献+

耐碳青霉烯类肠杆菌科细菌菌血症影响因素分析 被引量:9

Influencing factors of bactericemia induced by carbapenem-resistant Enterobacteriaceae
原文传递
导出
摘要 目的通过对医院获得性(Hospital-accquired,HA)耐碳青霉烯类肠杆菌科细菌(Carbapenem-resistant enterobacteriaceae,CRE)菌血症感染特征的分析,筛选出影响其感染的影响因素。方法选取2018年1月-2019年6月河北医科大学第二医院收治的138例医院获得性肠杆菌科细菌菌血症患者。以CRE患者为病例组(22例),对碳青霉烯类药物(Carbapenem,CA)敏感的肠杆菌科细菌感染患者为对照组(116例),两组间按照年龄±2岁、性别相同进行1∶2个体匹配。最终共筛选19对病例对照进行Logistic回归分析。结果两组患者在入院次数、体质量指数(Body Mass Index,BMI)、入院天数、一种非CA抗菌药物使用时间和30天内连续高热天数间的资料是可比的。单因素分析结果显示,感染前留置中心静脉导管、感染前使用CA类药物、感染前使用二联非CA类药物、感染前住院时间>14天、感染前侵入性操作、感染前特级护理或一级护理和BMI<24 kg/m^2对HA-CRE菌血症感染有一定影响(P<0.20);多因素分析结果显示,感染前留置中心静脉导管、感染前使用CA类药物、感染前使用二联非CA类药物和感染前接受一级护理或者特级护理是影响HA-CRE菌血症感染影响因素(P<0.05)。病例组患者的死亡率(21.05%)高于对照组患者的死亡率(0.00%)(P<0.05)。药敏试验结果显示,病例组对替加环素全部敏感,两组均对庆大霉素(P=0.355)和磺胺甲噁唑/甲氧苄啶中度敏感(P=0.223),对氨苄西林高度耐药(P=0.424),对头孢呋辛舒巴坦中度耐药((P=0.208)。结论医院获得性CRE菌血症对替加环素全部敏感,应实时监测细菌耐药,多部门联合重视并规范临床碳青霉烯类药物和两种抗菌药物联合应用。 OBJECTIVE To analysis the characteristics of hospital-acquired(HA)carbapenem-resistant Enterobacteriaceae(CRE)bacteremia,so as to screen the risk factor of nosocomial infection.METHODS A tota of 138 hospitalized patients with Enterobacteriaceae bacteremia in the second hospital of Heibei Medical University from Jan.of 2018 to Jun.of 2019 were collected.Patients with CRE were selected as case group(22 cases),and patients with carbapenem sensitive Enterobacteriaceae nosocomial bacteremia were selected as control group(116 cases).The two groups were matched by 1∶2 individuals according to age±2 years old and the same gender.And finally 19 pairs of case controls were screened for Logistic regression analysis.RESULTS Data on admission,BMI,the duration of hospital stay,the days of carbapenem-use and the consecutive fever-day with 30 days before the infections of two groups were comparable.Univariate analysis showed that indweling central venous catheter before infection,use of the carbapenem and two non-carbapenem antibiotics before infection,hospitalization time>14 days,the invasive operation before infection,one grade nursing or intensive care and BMI<24 kg/m^2 were likely the risk factor of CRE infections(P<0.20).While multivariate analysis showed that indwelling of central venous catheter before infection,use of the carbapenem and two non-carbapenem antibiotics before infection and grade one nursing or intensive care were the independent risk factor of CRE infections(P=0.355).The mortality rate in case group was significantly higher than that in the control group(21.05%vs.0.00%,respectively)(P=0.223).The susceptibiligy test showed that the case group were all sensitive to tigecycline.Both groups were moderately sensitive to gentamycin and compound sulfamethoxazole and highly resistant to ampicillin(P=0.424),whereas moderately resistant to cefuroxime sulbactam(P=0.208).CONCLUSION Hospital-acquired CRE bacteremia were all sensitive to tigecycline.Surveillance should be part of a multimodal strategy to prevent and control CRE infection.And great efforts should be paid to standardizing the use of carbapenem and the combination of two antibiotics by multi-sectoral joint.
作者 王黎一 史利克 王悦 刘燕 WANG Li-yi;SHI Li-ke;WANG Yue;LIU Yan(The Second Hospital of Hebei University,Shijiazhuang,Hebei 05000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2020年第3期321-326,共6页 Chinese Journal of Nosocomiology
基金 河北省医学科学研究重点基金资助项目(20180356)。
关键词 耐碳青霉烯类肠杆菌 医院获得性菌血症 病例对照 匹配 影响因素 Carbapenem-resistant enterobacteri Hospital-acquired bacteremia Case control Matching Influencing factor
  • 相关文献

参考文献7

二级参考文献61

  • 1Davies TA, Queenan AM, Brian J. Morrow Longitudinal sur- vey of carbapenem resistance and resistance mechanisms in En- terobacteriaceae and non-fermenters from the USA in 2007-09 [J]. J Antimicrob Chemother, 2011, 66(10): 2298-2307.
  • 2Magiorakos AP,Srinivasan A,Carey RB,et al.Multidrugresistant,extensively drug-resistant and pandrug-resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect,2012,18(3):268-281.
  • 3Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 4Giske CG,Monnet DL,Cars O,et al.Clinical and economic impact of common multidrug-resistant gram-negative bacilli[J].Antimicrob Agents Chemother,2008,52(3):813-821.
  • 5Tuon FF,Rocha JL,Toledo P,et al.Risk factors for KPCproducing Klebsiella pneumoniae bacteremia[J].Braz J Infect Dis,2012,16(5):416-419.
  • 6Bogdanovich T,Adams-Haduch JM,Tian GB,et al.Colistinresistant,Klebsiella pneumoniae carbapenemase(KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258[J].Clin Infect Dis,2011,53(4):373-376.
  • 7Michalopoulos AS,Karatza DC,Gregorakos L.Pharmacokinetic evaluation of colistin sodium[J].Expert Opin Drug Metab Toxicol,2011,7(2):245-255.
  • 8Souli M,Kontopidou FV,Papadomichelakis E,et al.Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1metallo-beta-lactamase in a Greek university hospital[J].Clin Infect Dis,2008,46(6):847-854.
  • 9Daikos GL,Petrikkos P,Psichogiou M,et al.Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections[J].Antimicrob Agents Chemother,2009,53(5):1868-1873.
  • 10Lee J,Patel G,Huprikar S,et al.Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection[J].J Clin Microbiol,2009,47(5):1611-1612.

共引文献7769

同被引文献102

引证文献9

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部